Request for Covid-19 Impact Assessment of this Report
The United States Neglected Tropical Diseases Drugs and Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neglected Tropical Diseases Drugs and Vaccine market, reaching US$ million by the year 2028. As for the Europe Neglected Tropical Diseases Drugs and Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Neglected Tropical Diseases Drugs and Vaccine players cover Artecef BV, GlaxoSmithKline, AstraZeneca, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neglected Tropical Diseases Drugs and Vaccine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Drugs
Vaccines
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2028
2.1.2 Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Type
2.2.1 Malaria
2.2.2 Ebola
2.2.3 Dengue
2.2.4 Chagas
2.2.5 Leishmaniasis
2.2.6 Other
2.3 Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)
2.4 Neglected Tropical Diseases Drugs and Vaccine Segment by Application
2.4.1 Drugs
2.4.2 Vaccines
2.5 Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
2.5.1 Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)
3 Neglected Tropical Diseases Drugs and Vaccine Market Size by Player
3.1 Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Players
3.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2020-2022)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2020-2022)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Neglected Tropical Diseases Drugs and Vaccine by Regions
4.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (2017-2022)
4.2 Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Growth (2017-2022)
4.3 APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Growth (2017-2022)
4.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Growth (2017-2022)
4.5 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
5.2 Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
5.3 Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022)
6.2 APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
6.3 APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine by Country (2017-2022)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine by Region (2017-2022)
8.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
8.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.1 Global Neglected Tropical Diseases Drugs and Vaccine Forecast by Regions (2023-2028)
10.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Forecast by Regions (2023-2028)
10.1.2 Americas Neglected Tropical Diseases Drugs and Vaccine Forecast
10.1.3 APAC Neglected Tropical Diseases Drugs and Vaccine Forecast
10.1.4 Europe Neglected Tropical Diseases Drugs and Vaccine Forecast
10.1.5 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Forecast
10.2 Americas Neglected Tropical Diseases Drugs and Vaccine Forecast by Country (2023-2028)
10.2.1 United States Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.2.2 Canada Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.2.3 Mexico Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.2.4 Brazil Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.3 APAC Neglected Tropical Diseases Drugs and Vaccine Forecast by Region (2023-2028)
10.3.1 China Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.3.2 Japan Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.3.3 Korea Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.3.4 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.3.5 India Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.3.6 Australia Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.4 Europe Neglected Tropical Diseases Drugs and Vaccine Forecast by Country (2023-2028)
10.4.1 Germany Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.4.2 France Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.4.3 UK Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.4.4 Italy Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.4.5 Russia Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.5 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Forecast by Region (2023-2028)
10.5.1 Egypt Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.5.2 South Africa Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.5.3 Israel Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.5.4 Turkey Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.5.5 GCC Countries Neglected Tropical Diseases Drugs and Vaccine Market Forecast
10.6 Global Neglected Tropical Diseases Drugs and Vaccine Forecast by Type (2023-2028)
10.7 Global Neglected Tropical Diseases Drugs and Vaccine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Artecef BV
11.1.1 Artecef BV Company Information
11.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Artecef BV Main Business Overview
11.1.5 Artecef BV Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Information
11.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi-Aventis Main Business Overview
11.5.5 Sanofi-Aventis Latest Developments
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Information
11.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Ranbaxy Labs Main Business Overview
11.6.5 Ranbaxy Labs Latest Developments
11.7 Lupin
11.7.1 Lupin Company Information
11.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Lupin Main Business Overview
11.7.5 Lupin Latest Developments
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Information
11.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Macleods Pharmaceuticals Main Business Overview
11.8.5 Macleods Pharmaceuticals Latest Developments
11.9 Cipla
11.9.1 Cipla Company Information
11.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Cipla Main Business Overview
11.9.5 Cipla Latest Developments
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Information
11.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Romark Laboratories Main Business Overview
11.10.5 Romark Laboratories Latest Developments
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Information
11.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Offered
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Toyama Chemica Main Business Overview
11.11.5 Toyama Chemica Latest Developments
12 Research Findings and Conclusion
Table 1. Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Malaria
Table 3. Major Players of Ebola
Table 4. Major Players of Dengue
Table 5. Major Players of Chagas
Table 6. Major Players of Leishmaniasis
Table 7. Major Players of Other
Table 8. Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)
Table 11. Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)
Table 14. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Player (2020-2022)
Table 16. Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Products Offered
Table 17. Neglected Tropical Diseases Drugs and Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Regions (2017-2022)
Table 22. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Country (2017-2022)
Table 24. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)
Table 26. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)
Table 28. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region (2017-2022)
Table 30. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)
Table 32. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)
Table 34. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Country (2017-2022)
Table 36. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)
Table 38. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Neglected Tropical Diseases Drugs and Vaccine
Table 47. Key Market Challenges & Risks of Neglected Tropical Diseases Drugs and Vaccine
Table 48. Key Industry Trends of Neglected Tropical Diseases Drugs and Vaccine
Table 49. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share Forecast by Application (2023-2028)
Table 55. Artecef BV Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 56. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 57. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Artecef BV Main Business
Table 59. Artecef BV Latest Developments
Table 60. GlaxoSmithKline Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 61. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 62. GlaxoSmithKline Main Business
Table 63. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. GlaxoSmithKline Latest Developments
Table 65. AstraZeneca Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 66. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 67. AstraZeneca Main Business
Table 68. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. AstraZeneca Latest Developments
Table 70. Novartis Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 71. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 72. Novartis Main Business
Table 73. Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. Novartis Latest Developments
Table 75. Sanofi-Aventis Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 76. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 77. Sanofi-Aventis Main Business
Table 78. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Sanofi-Aventis Latest Developments
Table 80. Ranbaxy Labs Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 81. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 82. Ranbaxy Labs Main Business
Table 83. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Ranbaxy Labs Latest Developments
Table 85. Lupin Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 86. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 87. Lupin Main Business
Table 88. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. Lupin Latest Developments
Table 90. Macleods Pharmaceuticals Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 91. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 92. Macleods Pharmaceuticals Main Business
Table 93. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Macleods Pharmaceuticals Latest Developments
Table 95. Cipla Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 96. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 97. Cipla Main Business
Table 98. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. Cipla Latest Developments
Table 100. Romark Laboratories Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 101. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 102. Romark Laboratories Main Business
Table 103. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Romark Laboratories Latest Developments
Table 105. Toyama Chemica Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors
Table 106. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Offered
Table 107. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Toyama Chemica Main Business
Table 109. Toyama Chemica Latest Developments
List of Figures
Figure 1. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type in 2021
Figure 7. Neglected Tropical Diseases Drugs and Vaccine in Drugs
Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market: Drugs (2017-2022) & ($ Millions)
Figure 9. Neglected Tropical Diseases Drugs and Vaccine in Vaccines
Figure 10. Global Neglected Tropical Diseases Drugs and Vaccine Market: Vaccines (2017-2022) & ($ Millions)
Figure 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Player in 2021
Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2022 ($ Millions)
Figure 15. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2022 ($ Millions)
Figure 16. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2022 ($ Millions)
Figure 18. Americas Neglected Tropical Diseases Drugs and Vaccine Value Market Share by Country in 2021
Figure 19. Americas Neglected Tropical Diseases Drugs and Vaccine Consumption Market Share by Type in 2021
Figure 20. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021
Figure 21. United States Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region in 2021
Figure 26. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021
Figure 27. China Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Country in 2021
Figure 34. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type in 2021
Figure 35. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021
Figure 36. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021
Figure 44. Egypt Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 50. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 51. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 53. United States Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 54. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 57. China Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 58. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 59. Korea Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 61. India Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 62. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 63. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 64. France Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 65. UK Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 66. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 67. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 68. Spain Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 71. Israel Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...